A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection

Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates

(2017) Jacques Simkins et al.   TRANSPLANTATION

Monitoring latent tuberculosis infection diagnosis and management in the Netherlands

(2016) Connie G.M. Erkens et al.   EUROPEAN RESPIRATORY JOURNAL

Impacts of 12-dose regimen for latent tuberculosis infection

(2016) Yi-Wen Huang et al.   MEDICINE

Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection

(2016) Andrea T. Cruz et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Predictors of Latent Tuberculosis Infection Treatment After Introduction of a New Regimen: A Retrospective Cohort Study at an Inner City Clinic

(2016) Aliya Yamin et al.   Open Forum Infectious Diseases

Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail: Table 1.

(2016) Maria Juarez-Reyes et al.   Open Forum Infectious Diseases

Latent Tuberculosis in Pregnancy: A Systematic Review

(2016) Isabelle Malhamé et al.   PLoS One

Treatment for Tuberculosis Infection With 3 Months of Isoniazid and Rifapentine in New York City Health Department Clinics

(2015) Natalie L. Stennis et al.   CLINICAL INFECTIOUS DISEASES

Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study

(2015) Timothy R. Sterling et al.   CLINICAL INFECTIOUS DISEASES

Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy

(2015) S-J. Park et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-γ-releasing assay: an exploratory randomized controlled trial

(2015) Sung-Han Kim et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Follow-up results of isoniazid chemoprophylaxis during biological therapy in Colombia

(2015) Juan Carlos Cataño et al.   RHEUMATOLOGY INTERNATIONAL

Treatment for Preventing Tuberculosis in Children and Adolescents

(2015) M. Elsa Villarino et al.   JAMA Pediatrics

Treatment of Latent Tuberculosis Infection

(2014) Helen R. Stagg et al.   ANNALS OF INTERNAL MEDICINE

Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in children

(2014) A. T. Cruz et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control

(2014) Gavin J. Churchyard et al.   NEW ENGLAND JOURNAL OF MEDICINE

P191 With A Low Incidence Of Drug-induced Hepatitis, Should We Be Offering Latent Tb Treatment To More Patients Over The Age Of 35?

(2014) P. Howlett et al.   THORAX

Hepatotoxicity in Children Receiving Isoniazid Therapy for Latent Tuberculosis Infection

(2014) S.-H. Chang et al.   Journal of the Pediatric Infectious Diseases Society

Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection

(2013) Dick Menzies et al.   ANNALS OF INTERNAL MEDICINE

Isoniazid preventive treatment: predictors of adverse events and treatment completion

(2013) L. R. Codecasa et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Rifampicin plus isoniazid for the prevention of tuberculosis in an immigrant population

(2013) M. A. Jiménez-Fuentes et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Female sex and discontinuation of isoniazid due to adverse effects during the treatment of latent tuberculosis

(2013) April C. Pettit et al.   JOURNAL OF INFECTION

Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents

(2013) Shiow-Huey Chang et al.   Journal of Infection and Public Health

The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection

(2012) T.-F. Tsai et al.   BRITISH JOURNAL OF DERMATOLOGY

Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial

(2012) P-C. Chan et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Successful Treatment of Pediatric Latent Tuberculosis Infection in a Community Health Center Clinic

(2012) Janine Young et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Adherence to isoniazid preventive therapy in children exposed to tuberculosis: a prospective study from Guinea-Bissau

(2011) V.F. Gomes et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

New Regimens to Prevent Tuberculosis in Adults with HIV Infection

(2011) Neil A. Martinson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

(2011) Timothy R. Sterling et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pauta de tres meses de rifampicina e isoniacida para el tratamiento de la infección latente tuberculosa

(2010) Carlos Salinas et al.   MEDICINA CLINICA

Rifampin Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection

(2009) Francis F. Fountain et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

A Retrospective Evaluation of Completion Rates, Total Cost, and Adverse Effects for Treatment of Latent Tuberculosis Infection in a Public Health Clinic in Central Massachusetts

(2009) Heather Young et al.   CLINICAL INFECTIOUS DISEASES

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

(2009) U. Mack et al.   EUROPEAN RESPIRATORY JOURNAL

An evidence-based practice guideline for the peer review of electronic search strategies

(2009) Margaret Sampson et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Factors Associated With Failure To Complete Isoniazid Treatment for Latent Tuberculosis Infection in Rhode Island

(2007) Awewura Kwara et al.   CHEST